Bellerophon Therapeutics, Inc.·4

Sep 14, 8:31 AM ET

FARES Wassim 4

4 · Bellerophon Therapeutics, Inc. · Filed Sep 14, 2020

Insider Transaction Report

Form 4
Period: 2020-09-10
FARES Wassim
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2020-09-10$10.18/sh+4,000$40,7084,000 total

Documents

1 file
  • 4
    wf-form4_160008668965139.xmlPrimary

    FORM 4